Drug-eluting Stents Current Events | Drug-eluting Stents News | 9
|
| Page
9 of
29 |
571 Results |
|
|
|
Sort By:
Page Views | Date |
Leading toxicologist warns against new drug of abuse
Professor Alison Jones said benzylpiperazine was a "new drug of abuse" which could have serious clinical effects - similar to those of ecstasy to which it is structurally related. view more (2007-04-30)
New image analysis techniques to monitor how breast tumours respond to drugs
New techniques that might allow magnetic resonance imaging (MRI), to be used to give doctors subtle information about a tumour’s physiology and how it reacts to drug therapy are being developed. view more (2001-12-18)
Cancer cells lose drug resistance following electrical stimulation in vitro
Drug-resistant tumour cells lose their drug resistance when exposed to low intensity, low frequency electric pulses for three days. view more (2006-03-17)
Scientists up the ante in war against "superbugs"
Scientists have discovered a weakness in tuberculosis-causing "superbugs" which could help doctors fight the emergence of multi-drug resistant tuberculosis, says Dr Jim Naismith speaking at the BA Festival of Science at the University of Glasgow today [3rd Spetember 2001]. Tuberculosis (TB) affects more than 50 million people worldwide.... view more... (2001-08-30)
Halting retrieval of drug-associated memories may prevent addiction relapse
Disrupting the brain's retrieval of drug-associated memories may prevent relapse in drug addiction, according to new research in the August 13 issue of The Journal of Neuroscience. view more (2008-08-13)
Selective amnesia — How a traumatic memory can be wiped out
French CNRS scientists in collaboration have shown that a memory of a traumatic event can be wiped out, although other, associated recollections remain intact. view more (2007-04-02)
Random drug testing not reliable in keeping teen athletes from using
Random drug and alcohol testing does not reliably keep student-athletes from using. In fact, the mere presence of drug testing increases some risk factors for future substance use, Oregon Health & Science University researchers report. view more (2007-10-19)
Malaria - breakthrough in understanding the side effects of mefloquine
Two British scientists, Dr Ashley Croft and Dr Andrew Herxheimer, have published a paper which for the first time tries to explain the adverse effects of the controversial antimalaria drug, mefloquine (Lariam®). view more (2002-04-23)
Late angioplasty after heart attack no better than drug therapy
About one-third of heart attack patients do not receive treatment to open blocked arteries within the recommended 12-hour timeframe after a heart attack. view more (2006-11-15)
Has drug regulation abandoned its public health mission?
Over the past 20 years, the pharmaceutical industry has skilfully managed to achieve an unhealthy influence over drug regulatory agencies, which may be threatening the public health needs of the European Union, according to an article in this week's BMJ. Professor John Abraham argues that European regulatory authorities, which were initially... view more... (2002-11-13)
Lower IQ found in children of women who took epilepsy drug
Children of women who took the epilepsy drug valproate during pregnancy appear to be at a greater risk for lower IQ. view more (2007-05-04)
Drug industry, nonprofits join forces to fight world's neglected diseases
Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. view more (2009-11-12)
Morphochem Signs Deal With AstraZeneca To Develop Novel Anti-thrombotics
Munich, November 21st 2002 "¦. Morphochem AG, a leader in evolutionary discovery of small molecule drugs, has entered into a research collaboration with AstraZeneca AB (Sweden) wherein Morphochem will apply its drug discovery engine, the MOREsystem™, to the discovery of compounds with novel structures with activity against an... view more... (2002-11-21)
New possibilities for drug design
An article in Journal of Physics B, published on 7 July 2003 by the Institute of Physics, reports on a new technique which could in future help scientists working in rational drug design (a way of tailoring a new drug to fit the structure of the protein it targets) to develop drugs more efficiently. The work, which was on a molecule called... view more... (2003-07-04)
Researchers develop new ways to predict number of drug users
A team of researchers have developed a new method of predicting the number of drug users in the population by looking at the number of recorded overdose deaths among drug users. view more (2004-11-11)
Can cancer drugs combine forces?
Individuals with chronic myeloid leukemia (CML) are treated first with a drug known as imatinib (Gleevec), which targets the protein known to cause the cancer (BCR-ABL). view more (2007-08-17)
Methotrexate treatment for rheumatoid arthritis effective the second time
A second course of methotrexate, the most commonly used drug to treat rheumatoid arthritis, is effective in nearly half of studied patients for whom a previous treatment with the drug was ineffective. view more (2006-02-24)
VTT develops one-step drug test
VTT Technical Research Centre of Finland has developed an inexpensive one-step drug test method that can instantly detect abuse of medicine, drugs and doping substances. The test instantly and accurately gives the results e.g. from a saliva sample. The test is unique internationally, as it enables the detection of similar substances accurately and... view more... (2004-01-29)
Vioxx: An Unequal Partnership Between Safety And Efficacy (p 1287)
Last week's dramatic withdrawal of the COX-2 inhibitor rofecoxib (Vioxx) is discussed in this week's lead editorial, which comments that more vigilant drug licensing is vital to prevent the endangering of patients' health. view more (2004-10-06)
Failed HIV Drug Gets Second Chance with Addition of Gold Nanoparticles
Researchers at North Carolina State University have discovered that adding tiny bits of gold to a failed HIV drug rekindle the drug's ability to stop the virus from invading the body's immune system. view more (2008-05-27)
|
|
| Page
9 of
29 |
571 Results |
|
|
|
Sort By:
Page Views | Date |
|
